SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-22-038170
Filing Date
2022-03-25
Accepted
2022-03-25 17:12:47
Documents
6
Effectiveness Date
2022-03-25

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2210359d1_s8.htm S-8 58668
2 EXHIBIT 5.1 tm2210359d1_ex5-1.htm EX-5.1 8514
3 EXHIBIT 23.1 tm2210359d1_ex23-1.htm EX-23.1 2530
4 EXHIBIT 23.2 tm2210359d1_ex23-2.htm EX-23.2 2844
5 EX-FILING FEES tm2210359d1_ex-fillingfees.htm EX-FILING FEES 12668
6 GRAPHIC tm2210359d1_ex5-1img001.jpg GRAPHIC 3134
  Complete submission text file 0001104659-22-038170.txt   90808
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263869 | Film No.: 22772368
SIC: 2834 Pharmaceutical Preparations